• News
  • SAN DIEGO
  • Finance

Valeant, Ackman make $45B Allergan bid

Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45 billion.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!